ASX - By Stock
|
TAH |
Re:
Ann: MD and CEO to leave Tabcorp
|
|
Edubear
|
8 |
2.7K |
5 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
8
|
2.7K
|
5
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Travelan to progress to Phase 3 Clinical Trials in the US
|
|
Edubear
|
164 |
42K |
7 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
164
|
42K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
X
|
|
Edubear
|
9 |
2.2K |
2 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
9
|
2.2K
|
2
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Edubear
|
971 |
226K |
2 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
971
|
226K
|
2
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Edubear
|
971 |
226K |
6 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
971
|
226K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Presentation - Phase 1 Top-Line Results
|
|
Edubear
|
34 |
10K |
14 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
34
|
10K
|
14
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Investor webinar - Phase 1 MND Study Top-Line Results
|
|
Edubear
|
209 |
46K |
1 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
209
|
46K
|
1
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Edubear
|
971 |
226K |
9 |
23/02/24 |
23/02/24 |
ASX - By Stock
|
971
|
226K
|
9
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Edubear
|
971 |
226K |
24 |
22/02/24 |
22/02/24 |
ASX - By Stock
|
971
|
226K
|
24
|
|
ASX - By Stock
|
VML |
Re:
Ann: Request for Extension of Voluntary Suspension
|
|
Edubear
|
20 |
7.3K |
6 |
14/12/23 |
14/12/23 |
ASX - By Stock
|
20
|
7.3K
|
6
|
|
ASX - By Stock
|
SGR |
Re:
Ann: Proposed reforms to Queensland casino regulation
|
|
Edubear
|
16 |
4.9K |
1 |
27/10/23 |
27/10/23 |
ASX - By Stock
|
16
|
4.9K
|
1
|
|
ASX - By Stock
|
VML |
Re:
News: VML Shenghe Resources Unit's Singapore Firm To Subscribe New Shares In Vital Metals
|
|
Edubear
|
2 |
947 |
8 |
23/10/23 |
23/10/23 |
ASX - By Stock
|
2
|
947
|
8
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
Edubear
|
11K |
4.1M |
8 |
18/10/23 |
18/10/23 |
ASX - By Stock
|
11K
|
4.1M
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Options Offer to Existing Listed Option Holders
|
|
Edubear
|
79 |
15K |
8 |
18/10/23 |
18/10/23 |
ASX - By Stock
|
79
|
15K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Notification of expiry of quoted options
|
|
Edubear
|
43 |
8.7K |
4 |
30/09/23 |
30/09/23 |
ASX - By Stock
|
43
|
8.7K
|
4
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
Edubear
|
7.7K |
2.8M |
0 |
28/09/23 |
28/09/23 |
ASX - By Stock
|
7.7K
|
2.8M
|
0
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Presentation- FDA Letter Requires Patient Instruction Update
|
|
Edubear
|
68 |
15K |
1 |
26/09/23 |
26/09/23 |
ASX - By Stock
|
68
|
15K
|
1
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Response to ASX Price and Volume Query
|
|
Edubear
|
54 |
18K |
15 |
20/09/23 |
20/09/23 |
ASX - By Stock
|
54
|
18K
|
15
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, The New Dawn, September , Optober 2023
|
|
Edubear
|
132 |
32K |
10 |
14/09/23 |
14/09/23 |
ASX - By Stock
|
132
|
32K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Additional Phase 1 data suggest MPL may inhibit MND
|
|
Edubear
|
380 |
80K |
8 |
22/08/23 |
22/08/23 |
ASX - By Stock
|
380
|
80K
|
8
|
|
ASX - By Stock
|
IMU |
Re:
Bulls and bears 3aw
|
|
Edubear
|
14 |
9.6K |
32 |
28/07/23 |
28/07/23 |
ASX - By Stock
|
14
|
9.6K
|
32
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Oncolytic Virotherapy CF33 Patent Allowed in the US
|
|
Edubear
|
103 |
47K |
26 |
19/07/23 |
19/07/23 |
ASX - By Stock
|
103
|
47K
|
26
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Louie the Beagle surpasses one year on MPL
|
|
Edubear
|
37 |
7.2K |
5 |
06/07/23 |
06/07/23 |
ASX - By Stock
|
37
|
7.2K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Louie the Beagle surpasses one year on MPL
|
|
Edubear
|
37 |
7.2K |
15 |
06/07/23 |
06/07/23 |
ASX - By Stock
|
37
|
7.2K
|
15
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Edubear
|
22K |
10M |
15 |
27/06/23 |
27/06/23 |
ASX - By Stock
|
22K
|
10M
|
15
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Advances VAXINIA MAST Trial to Next IV Cohorts
|
|
Edubear
|
233 |
105K |
50 |
09/06/23 |
09/06/23 |
ASX - By Stock
|
233
|
105K
|
50
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Investor Webinar Presentation
|
|
Edubear
|
69 |
23K |
8 |
07/06/23 |
07/06/23 |
ASX - By Stock
|
69
|
23K
|
8
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Botanix Investor Webinar
|
|
Edubear
|
38 |
14K |
12 |
07/06/23 |
07/06/23 |
ASX - By Stock
|
38
|
14K
|
12
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Immuron Initiates Recruitment of Travelan Clinical Study
|
|
Edubear
|
1 |
840 |
2 |
30/05/23 |
30/05/23 |
ASX - By Stock
|
1
|
840
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Ann: onCARlytics with Artemis T cells abstract presented at ASGCT
|
|
Edubear
|
95 |
42K |
33 |
03/05/23 |
03/05/23 |
ASX - By Stock
|
95
|
42K
|
33
|
|
ASX - By Stock
|
IMU |
Re:
March Roadshows
|
|
Edubear
|
387 |
171K |
31 |
16/03/23 |
16/03/23 |
ASX - By Stock
|
387
|
171K
|
31
|
|
ASX - By Stock
|
GLN |
Re:
General Discussion Banter GLN
|
|
Edubear
|
14K |
5.7M |
10 |
16/12/22 |
16/12/22 |
ASX - By Stock
|
14K
|
5.7M
|
10
|
|
ASX - By Stock
|
VML |
Re:
News: VML Vital Metals Announces Termination Of Agreement To Acquire Kipawa And Zeus Projects
|
|
Edubear
|
37 |
18K |
8 |
13/10/22 |
13/10/22 |
ASX - By Stock
|
37
|
18K
|
8
|
|
ASX - By Stock
|
CXO |
Re:
Banter and general comments
|
|
Edubear
|
37K |
16M |
12 |
22/06/22 |
22/06/22 |
ASX - By Stock
|
37K
|
16M
|
12
|
|
ASX - By Stock
|
IMU |
Re:
Ann: IMUGENE DOSES FIRST PATIENT IN VAXINIA PHASE 1 TRIAL
|
|
Edubear
|
159 |
93K |
20 |
18/05/22 |
18/05/22 |
ASX - By Stock
|
159
|
93K
|
20
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Epichem CEO
|
|
Edubear
|
25 |
6.0K |
3 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
25
|
6.0K
|
3
|
|
ASX - By Stock
|
IMU |
Re:
Ann: South Korea HERVaxx Patent Grant
|
|
Edubear
|
78 |
37K |
4 |
06/01/22 |
06/01/22 |
ASX - By Stock
|
78
|
37K
|
4
|
|
ASX - By Stock
|
IMU |
Re:
Ann: South Korea HERVaxx Patent Grant
|
|
Edubear
|
78 |
37K |
5 |
06/01/22 |
06/01/22 |
ASX - By Stock
|
78
|
37K
|
5
|
|
ASX - By Stock
|
IMU |
Re:
Ann: South Korea HERVaxx Patent Grant
|
|
Edubear
|
78 |
37K |
13 |
06/01/22 |
06/01/22 |
ASX - By Stock
|
78
|
37K
|
13
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Investor Presentation
|
|
Edubear
|
7 |
3.2K |
7 |
22/12/21 |
22/12/21 |
ASX - By Stock
|
7
|
3.2K
|
7
|
|
ASX - By Stock
|
OCC |
Re:
OCC Options
|
|
Edubear
|
23 |
6.1K |
5 |
22/12/21 |
22/12/21 |
ASX - By Stock
|
23
|
6.1K
|
5
|
|
ASX - By Stock
|
IBX |
Re:
IBX Chart
|
|
Edubear
|
287 |
103K |
7 |
22/11/21 |
22/11/21 |
ASX - By Stock
|
287
|
103K
|
7
|
|
ASX - By Stock
|
VML Mining |
Re:
VML General Comments - Chat
|
|
Edubear
|
8.3K |
3.5M |
4 |
12/11/21 |
12/11/21 |
ASX - By Stock
|
8.3K
|
3.5M
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Monsoon Presentation
|
|
Edubear
|
72 |
13K |
7 |
11/11/21 |
11/11/21 |
ASX - By Stock
|
72
|
13K
|
7
|
|
ASX - By Stock
|
SPR |
Re:
Ann: Trading Halt
|
|
Edubear
|
57 |
20K |
7 |
11/06/21 |
11/06/21 |
ASX - By Stock
|
57
|
20K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Leiden Testing Indicates MPL SARS-CoV-2 Antiviral Activity
|
|
Edubear
|
732 |
141K |
7 |
13/05/21 |
13/05/21 |
ASX - By Stock
|
732
|
141K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Leiden Testing Indicates MPL SARS-CoV-2 Antiviral Activity
|
|
Edubear
|
732 |
141K |
12 |
09/04/21 |
09/04/21 |
ASX - By Stock
|
732
|
141K
|
12
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Covi-Pantel . NZ Trader Release
|
|
Edubear
|
1.4K |
309K |
5 |
08/03/21 |
08/03/21 |
ASX - By Stock
|
1.4K
|
309K
|
5
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
Edubear
|
7.7K |
2.8M |
1 |
04/03/21 |
04/03/21 |
ASX - By Stock
|
7.7K
|
2.8M
|
1
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Covi-Pantel . NZ Trader Release
|
|
Edubear
|
1.4K |
309K |
8 |
10/02/21 |
10/02/21 |
ASX - By Stock
|
1.4K
|
309K
|
8
|
|